• Increase
  • Decrease
  • Normal

Current Size: 100%

  • IWMF members

    All the photos on our website are IWMF members.

  • Living With WM

    There are many patients with Waldenstrom’s macroglobulinemia (WM) who are living well and enjoying life with a degree of contentment that may seem surprising to others.

  • Imagine a Cure

    We have a goal of raising $9,000,000 to support WM research and vital member services through both current gifts and legacy gifts.

We support everyone affected by Waldenstrom's macroglobulinemia
while advancing the search for a cure.

Find Out About

Important News &
Key Events


August 7, 2015

IWMF is partnering with the U.S.-based cancer support services organization, CancerCare, in a Connect Education Workshop on WM. On Wednesday, September 2nd, from 1:30 – 2:30PM...

July 31, 2015

Dr. Robert Kyle, Professor of Medicine and Laboratory Medicine and Pathology at Mayo Clinic and noted international expert on WM, recently celebrated a landmark 52-year anniversary

July 10, 2015

AbbVie announced on July 10, 2015, that the European Commission has granted marketing authorization for Imbruvica (ibrutinib) for the treatment of Waldenstrom’s macroglobulinemia.


August 29, 2015
St. Francis Hospital, 5959 Park Avenue St. Clare Conference Room
Memphis , TN
United States
35° 5' 55.0176" N, 89° 51' 50.2488" W
August 30, 2015
130 S. Bryn Mawr Ave. Bryn Mawr Hospital - Room E, Lobby Level
Bryn Mawr , PA
United States
40° 1' 7.6728" N, 75° 19' 16.6116" W
September 2, 2015
275 Seventh Avenue
New York , NY
United States
40° 44' 43.602" N, 73° 59' 39.138" W

This website is supported in part by unrestricted educational grants from Gilead Sciences, Inc. ,
Idera Pharmaceuticals , and Onyx Pharmaceuticals, an Amgen subsidiary